Review
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Dec 15, 2021; 12(12): 1979-1999
Published online Dec 15, 2021. doi: 10.4239/wjd.v12.i12.1979
Thioredoxin interacting protein, a key molecular switch between oxidative stress and sterile inflammation in cellular response
Islam N Mohamed, Luling Li, Saifudeen Ismael, Tauheed Ishrat, Azza B El-Remessy
Islam N Mohamed, Luling Li, Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, California North State University, Elk Grove, CA 95758, United States
Saifudeen Ismael, Tauheed Ishrat, Department of Anatomy and Neurobiology, and Neuroscience Institute, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, United States
Azza B El-Remessy, Department of Pharmacy, Doctors Hospital of Augusta, Augusta, GA 30909, United States
Author contributions: Mohamed IN, Li L, and Ismael S drafted the article; Ishrat T and El-Remessy AB critically edited the article and all authors reviewed the final version of the article.
Conflict-of-interest statement: The authors declare that they have no personal interests.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Azza B El-Remessy, PharmD, PhD, Pharmacist, Department of Pharmacy, Doctors Hospital of Augusta, Wheeler Rd Augusta, GA 30909, United States. aelremessy@outlook.com
Received: June 30, 2021
Peer-review started: June 30, 2021
First decision: July 28, 2021
Revised: September 1, 2021
Accepted: December 2, 2021
Article in press: December 2, 2021
Published online: December 15, 2021
Processing time: 169 Days and 6.5 Hours
Abstract

Tissue and systemic inflammation have been the main culprit behind the cellular response to multiple insults and maintaining homeostasis. Obesity is an independent disease state that has been reported as a common risk factor for multiple metabolic and microvascular diseases including nonalcoholic fatty liver disease (NAFLD), retinopathy, critical limb ischemia, and impaired angiogenesis. Sterile inflammation driven by high-fat diet, increased formation of reactive oxygen species, alteration of intracellular calcium level and associated release of inflammatory mediators, are the main common underlying forces in the pathophysiology of NAFLD, ischemic retinopathy, stroke, and aging brain. This work aims to examine the contribution of the pro-oxidative and pro-inflammatory thioredoxin interacting protein (TXNIP) to the expression and activation of NLRP3-inflammasome resulting in initiation or exacerbation of sterile inflammation in these disease states. Finally, the potential for TXNIP as a therapeutic target and whether TXNIP expression can be modulated using natural antioxidants or repurposing other drugs will be discussed.

Keywords: Thioredoxin interacting protein; NOD-like receptor pyrin domain containing 3; Inflammasome; Interleukin 1b; Inflammation; Obesity; High-fat diet; Ischemia; Reperfusion; Oxidative stress

Core Tip: Inflammation has been postulated as the central pathway involved in maintaining homeostasis and in cellular response to insults. High fat diet-induced inflammasome activation have been reported to predispose microvascular diseases including retinopathy, and nonalcoholic fatty liver disease. Inflammation can alter vascular recovery in response to ischemic insult including ischemic retinopathy, stroke and critical limb ischemia. Thioredoxin interacting protein (TXNIP) is required for the activation but not necessarily for expression of NOD-like receptor pyrin domain containing 3-inflammasome resulting in initiation or exacerbation of the disease state. A list of natural antioxidants or repurposed drugs is included to modulate TXNIP expression.